Hemanext

Hemanext is a medical technology company based in Lexington, MA, founded in 2004. The company focuses on innovative solutions for transfusion medicine, aiming to enhance the quality, safety, and efficacy of transfusion therapy. Hemanext is dedicated to improving the standard of care for patients who rely on transfusions by optimizing the therapeutic impact of blood.

The primary product offered by Hemanext is the Hemanext ONE system, an FDA-authorized device that processes and stores red blood cells. This system creates hypoxic red blood cells, which maintain reduced oxygen and carbon dioxide levels during storage for up to 42 days, ensuring the quality and viability of the cells. Hemanext operates on a consumable model, facilitating easy integration into existing workflows for healthcare providers. The company is expanding its presence in hospitals and blood centers across the U.S. and is involved in initiatives related to sickle cell disease through partnerships and consortiums.